Healthcare Global Enterprises Share Price Today | Stock Price & Healthcare Global Enterprises Share Screener
As of October 5, 2026, the live Healthcare Global Enterprises share price (NSE: HCG) is ₹669.05 on NSE and ₹668.75 on BSE, up 0.04% from the previous close, with shares trading between ₹658.65 and ₹670.90 in today's trading session, and a 52-week range of ₹521.75–₹776.30. Check Healthcare Global Enterprises 52-week for the annual price range and momentum. Use the Healthcare Global Enterprises stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Healthcare Global Enterprises opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹664 and net income of ₹4, with EBITDA of ₹105, an operating margin of 14.0% and a profit margin of 0.6%.
Healthcare Global Enterprises Share Price Chart
Track the current stock price of Healthcare Global Enterprises with an interactive chart. Analyse HCG share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Healthcare Global Enterprises stock quote in one place.
The quote of ₹669.05 sits between the 52-week low of ₹521.75 and the 52-week high of ₹776.30, and the latest session moved 0.04% from the previous close.
Healthcare Global Enterprises Company Profile - Fundamental Screener
Screen Healthcare Global Enterprises company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for HCG shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Hospitals industry, and it trades under ISIN INE075I01017.
Company Details
Classification
Identifiers and Leadership
Healthcare Global Enterprises Balance Sheet Screener
Screen HCG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹3,923, up from ₹3,543 in 2025.
Latest statistics put total assets at ₹3,923 and shareholder funds at ₹1,410, with a leverage ratio of 1.58.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 3,923 | 3,543 | 2,708 | 2,316 | 2,220 | 2,036 | 2,253 | 1,654 | 1,444 | 1,226 |
| Current Assets | 1,135 | 844 | 680 | 580 | 502 | 435 | 304 | 273 | 220 | 244 |
| Fixed Assets | 2,462 | 2,442 | 1,758 | 1,553 | 1,547 | 1,382 | 1,646 | 970 | 828 | 685 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1,495 | 1,507 | 1,099 | 876 | 866 | 856 | 1,258 | 584 | 506 | 371 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 1,410 | 990 | 865 | 869 | 884 | 714 | 420 | 522 | 579 | 490 |
| Share Capital | 149 | 139 | 139 | 139 | 139 | 125 | 89 | 88 | 87 | 86 |
| Reserves & Surplus | 1,183 | 783 | 687 | 721 | 731 | 528 | 293 | 389 | 398 | 347 |
Healthcare Global Enterprises Income Statement Screener - Profit & Revenue Analysis
Screen Healthcare Global Enterprises income statement and profit fundamentals. Analyze HCG quarterly results. Healthcare Global Enterprises reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Mar, revenue was ₹664 and net profit was ₹4, equal to earnings per unit of ₹0.15, at an operating margin of 14%.
In that period expenses were ₹559, interest cost ₹43 and tax ₹-3. The next period listed, 2026-Jun, shows revenue of ₹707 and net profit of ₹17.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 664 | 707 | 594 | 619 | 648 | 634 | 502 | 534 | 564 | 563 | 446 | 463 | 489 | 475 | 367 |
| Expenses | 559 | 573 | 480 | 505 | 524 | 536 | 403 | 435 | 451 | 470 | 365 | 386 | 402 | 391 | 302 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 105 | 134 | 114 | 114 | 125 | 98 | 100 | 99 | 112 | 93 | 80 | 76 | 87 | 84 | 65 |
| Operating Profit % | 14.00% | 17.00% | 18.00% | 17.00% | 19.00% | 15.00% | 18.00% | 17.00% | 18.00% | 16.00% | 17.00% | 16.00% | 17.00% | 17.00% | 17.00% |
| Depreciation | 63 | 70 | 58 | 58 | 63 | 61 | 46 | 47 | 50 | 57 | 42 | 41 | 43 | 44 | 41 |
| Interest | 43 | 40 | 44 | 46 | 44 | 45 | 27 | 34 | 36 | 41 | 26 | 26 | 27 | 30 | 24 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 1 | 25 | 14 | 12 | 20 | -6 | 28 | 19 | 28 | -3 | 13 | 11 | 18 | 11 | 1 |
| Tax | -3 | 9 | 7 | 6 | -1 | 2 | 5 | 5 | 7 | -11 | 8 | 7 | 7 | 8 | -1 |
| Net Profit | 4 | 17 | 7 | 6 | 21 | -8 | 24 | 14 | 21 | 8 | 6 | 4 | 11 | 3 | 2 |
| EPS | 0.15 | 0.92 | 0.53 | 0.34 | 1.16 | -0.68 | 1.53 | 0.87 | 1.29 | 0.50 | 0.60 | 0.55 | 0.97 | 0.41 | 0.43 |
Healthcare Global Enterprises Cash Flow Screener - Liquidity Fundamentals
Screen HCG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹347, and net cash flow was an inflow of ₹410.
Over the same period, investing activities used ₹178 and financing activities provided ₹241.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 347 | 317 | 285 | 252 | 220 | 121 | 130 | 99 | 98 | 91 |
| Investing Activities | -178 | -488 | -226 | -133 | 125 | -171 | -101 | -238 | -283 | -210 |
Financing and Net Cash | ||||||||||
| Financing Activities | 241 | -42 | -64 | -140 | -155 | 112 | -58 | 84 | 161 | 89 |
| Net Cash Flow | 410 | -213 | -5 | -22 | 190 | 62 | -30 | -56 | -24 | -29 |
Healthcare Global Enterprises Shareholding Pattern Screener
See Healthcare Global Enterprises shareholding pattern with promoter, FII, and DII holdings. Check Healthcare Global Enterprises promoter holding and ownership changes for HCG on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 64.21%, foreign institutions 2.75%, domestic institutions 18.91% and the public 10.79%, spread across 47,576 shareholders.
The shareholder count was 47,576 in 2026-Mar, compared with 48,905 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 64.21% | 64.21% | 71.22% | 62.46% | 63.78% | 63.77% | 71.28% | 71.25% |
Institutional Investors | ||||||||
| FII Holding | 2.75% | 2.74% | 2.45% | 2.16% | 3.59% | 3.22% | 6.74% | 3.95% |
| DII Holding | 18.91% | 19.20% | 12.47% | 13.22% | 18.36% | 18.30% | 8.52% | 10.89% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 10.79% | 10.83% | 10.43% | 10.50% | 10.41% | 11.20% | 9.39% | 9.41% |
| Other Holding | 3.34% | 3.02% | 3.43% | 11.66% | 3.86% | 3.51% | 4.07% | 4.49% |
| Shareholder Count | 47,576 | 48,905 | 45,394 | 47,028 | 46,970 | 45,366 | 27,195 | 26,529 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Healthcare Global Enterprises. Healthcare Global Enterprises dividend yield can be compared with peers and other stocks in the market.
Healthcare Global Enterprises Stock Index Membership - Nifty & Sensex
See which indices include Healthcare Global Enterprises stock. Check HCG index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 5 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP, NIFTY MICROCAP250.
Complete Index List
Healthcare Global Enterprises Market Events Screener - Corporate Actions
Get Healthcare Global Enterprises corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Healthcare Global Enterprises stock events that may affect HCG share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 18, 2026, with a record date of September 18, 2026.
It is followed by Quarterly Result Announcement dated August 6, 2026 and Quarterly Result Announcement dated May 19, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-18 | 2026-09-18 | Annual General Meeting | NA | -2.36% |
| 2026-08-06 | 2026-08-06 | Quarterly Result Announcement | NA | 0.47% |
| 2026-05-19 | 2026-05-19 | Quarterly Result Announcement | NA | 10.43% |
| 2026-03-02 | 2026-03-02 | Rights | 1:17 | -2.88% |
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | -3.32% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.45% |
| 2025-09-25 | 2025-09-25 | Annual General Meeting | NA | -6.34% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | 9.83% |
| 2025-05-24 | 2025-05-24 | Quarterly Result Announcement | NA | 7.76% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -3.65% |
| 2024-11-09 | 2024-11-09 | Quarterly Result Announcement | NA | 9.06% |
| 2024-09-25 | 2024-09-25 | Annual General Meeting | NA | 5.32% |
Healthcare Global Enterprises Competitors Screener - Peer Stocks Comparison
Screen HCG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 126,581 | 58.67 | 25,420 | 15.58% | 2,003 | 50.96 |
| Max Healthcare Institute | 96,507 | 66.86 | 8,536 | 18.82% | 1,442 | 40.71 |
| Aster DM Quality Care | 65,101 | 179.76 | 4,769 | 11.25% | 427 | 40.99 |
| Fortis Healthcare | 62,035 | 58.65 | 9,179 | 16.93% | 1,064 | 27.19 |
| Global Health | 37,970 | 69.81 | 4,509 | 19.56% | 554 | 46.95 |
| Narayana Hrudayalaya | 37,030 | 45.50 | 7,996 | 43.43% | 811 | 41.22 |
| Krishna Institute of Medical Sciences | 32,595 | 165.49 | 3,931 | 28.16% | 242 | 43.81 |
| Dr. Agarwal's Health Care | 15,572 | 86.39 | 2,125 | 20.92% | 168 | 50.48 |
| Rainbow Childrens Medicare | 13,911 | 48.05 | 1,747 | 11.49% | 282 | 32.52 |
| Park Medi World | 11,792 | 40.25 | 1,711 | 19.99% | 274 | 42.43 |
Healthcare Global Enterprises Company Announcements - News & Reports Screener
Screen HCG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated September 26, 2026.
The next most recent announcements are dated September 26, 2026 and September 17, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-09-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-26 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-16 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-09 | Intimation Of Grant Of Employee Stock Options Under Healthcare Global Enterprises Limited- Employee Stock Option Scheme 2026 | - |
| 2026-08-28 | Letter To Members Of The Company Containing Weblink And Path Of Integrated Annual Report For The Financial Year 2025-26. | - |
| 2026-08-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-27 | Notice Of 28Th Annual General Meeting Of The Company For FY 2025-26. | - |
| 2026-08-27 | Reg. 34 (1) Annual Report. | - |
| 2026-08-27 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-08-25 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-08 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-08-06 | Statement Of Variation Or Deviation Of The Proceeds Of Rights Issue For The Quarter Ended June 30 2026. | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Change in Management | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹669.05, within a 52-week range of ₹521.75 to ₹776.30. The P/E ratio is 310.47 and the P/B ratio is 7.76, with earnings per unit of ₹0.97. Market capitalisation stands at ₹10,378.00 Cr. The company operates in the Healthcare Services sector, in the Hospitals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.